Stay updated on ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site revision label in the footer changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-03T16:58:24.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The study record history page remains unchanged, displaying the submitted versions of the clinical trial record and the sections updated in each version.
    Difference
    0.1%
    Check dated 2026-10-27T16:37:47.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434. The site revision number changes from v3.7.1 to v3.7.2.
    Difference
    0.7%
    Check dated 2026-10-20T18:57:14.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer release identifier changes from v3.7.0 to v3.7.1; the study record history remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-06T19:26:19.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The study record history now shows a new revision entry v3.7.0, and the previously listed revision v3.6.6 has been removed.
    Difference
    0.1%
    Check dated 2026-09-15T22:26:10.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.6' appears in the study record history. This replaces the previous 'Revision: v3.6.5' and indicates an additional update to the record.
    Difference
    0.1%
    Check dated 2026-09-01T19:46:18.000Z thumbnail image

Stay in the know with updates to ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial page.